Home / Regenerative medicine / Prices & patient guide
Colombia · Mexico · Costa Rica

Stem cell therapy in Latin America, without the hype.

Educational price ranges, the five questions to ask any clinic, and an honest look at what the research shows for your condition.

Check the evidence for my conditionSee price ranges ↓
  • 18 conditions reviewed
  • 3 countries compared
  • 0 cure claims
A physician reviewing a knee MRI with a patient before any treatment decision
Choose the science first. Then the physician, then the laboratory — then the price.

Price should never be the deciding factor.

The experience of the physician, the qualifications of the medical team and the scientific standards of the laboratory matter far more than the number on a quote.

Estimated treatment price ranges (USD)

What patients typically see quoted

Broad, illustrative planning ranges — not verified clinic quotations. Actual costs depend on the condition, cell source, treatment protocol, number of sessions and services included.

Colombia

$5,000–$15,000+

Educational range

Mexico

$6,000–$20,000+

Educational range

Costa Rica

$8,000–$25,000+

Educational range

A lower price does not automatically mean poor quality, just as a higher price does not guarantee better treatment or results.

We do our homework

Advanced stem cell protocols: beyond standard treatment.

Standard stem cell treatments may be available at lower prices. There is another category of regenerative medicine: advanced, physician-led protocols supported by laboratory science, individualized testing and a deeper investigation into each patient’s medical condition.

These programs go beyond simply giving stem cells intravenously or injecting them into an affected joint. They are designed to evaluate the patient’s broader health, identify possible contributing factors and decide whether a more comprehensive approach is medically appropriate.

A physician reviewing test results on a tablet with a patient
  • Sterilitytested
  • Cell identityconfirmed
  • Viabilitymeasured
  • Traceabilitydocumented
Physician + laboratory review before any recommendation
Four levels of care

Four levels of personalized regenerative medicine & advanced care

From physician-led treatment planning to comprehensive, year-long personalized medical oversight.

01Initial treatment program

Essential Regenerative Care

$5,000–$25,000+

  • Physician-led assessment
  • Medical history review
  • Baseline diagnostics
  • Individualized treatment planning
  • Laboratory quality review
  • Post-treatment follow-up
02Customized treatment program

Advanced Precision Regenerative Protocol

$17,000–$25,000

  • Multidisciplinary physician and laboratory specialist collaboration
  • Expanded diagnostic testing
  • Personalized clinical planning
  • Evaluation of appropriate targeted interventions
  • Structured follow-up
03Semester program · 6 months

Executive Regenerative Care

$45,000–$75,000

  • Comprehensive personalized care with ongoing specialist oversight
  • Scheduled diagnostic reassessments
  • Biomarker monitoring
  • Treatment-response evaluation
  • Care plan adjusted to clinical findings
0412 months

Platinum Precision Medicine & Longevity Program

Up to $190,000+

  • Our most comprehensive personalized program
  • Dedicated research specialist and multidisciplinary medical team
  • Longitudinal biomarker monitoring
  • Quarterly clinical evaluations and ongoing research reviews
  • Dedicated patient advocacy and coordinated medical oversight all year

Illustrative program price ranges, not guarantees of treatment effectiveness. Higher prices do not necessarily mean better outcomes. Essential care pricing varies by country (see ranges above).

Our philosophy

Beyond one-size-fits-all medicine

Every patient presents a unique clinical picture. Whether addressing multiple sclerosis, liver disease, diabetes, cardiovascular conditions or complex age-related concerns, our approach begins with understanding the individual — not simply selecting a treatment from a menu.

The difference between our programs is the depth of clinical evaluation, level of personalization, specialist involvement and duration of ongoing medical oversight.

Advanced medicine is not defined by how much treatment is administered, but by the expertise, evidence, precision and accountability behind every medical decision.

All interventions are subject to physician approval, clinical eligibility, applicable regulatory requirements and informed consent. Investigational regenerative therapies are not guaranteed to regenerate tissue, reverse disease or improve outcomes.

Choose a program for my condition

What separates an advanced protocol from a standard treatment?

One of the most important differences is collaboration between an experienced treating physician and qualified laboratory scientists, including microbiologists with relevant cell-processing expertise.

The physician

Evaluates your condition, clinical history, imaging and treatment options.

The laboratory

Cell characterization, quality control, sterility testing, viability and processing procedures.

When these disciplines work together in an appropriately regulated clinical and laboratory environment, they can support a more individualized, scientifically informed approach.

An advanced protocol may involve

  1. Comprehensive medical-history review and diagnostic testing before treatment
  2. Assessment of whether you are an appropriate candidate
  3. Evaluation of laboratory quality standards and cell-processing methods
  4. Systemic versus targeted delivery, including direct injections when medically justified
  5. Review of published research, clinical trials and established safety data
  6. Structured follow-up to monitor outcomes and possible side effects

Evidence matters more than promises

No responsible physician or clinic can guarantee that stem cell therapy will regenerate damaged tissue, reverse disease or produce a particular outcome. Evidence varies by condition, cell type, route of administration and protocol, and some approaches remain investigational.

Direct injections or systemic administration do not automatically ensure that cells will reach, survive in or repair the intended tissue. The goal is never to rely on chance or assume more cells means better results — it is to decide based on the best available evidence, appropriate testing, clinical judgment and realistic expectations.

Why one size does not fit all

Two patients may share a diagnosis but have very different medical histories, disease severity, medications, laboratory results and risks. Their protocol should not automatically be the same either.

The real value of a comprehensive program comes from the quality of the assessment, the expertise of the professionals, the integrity of the laboratory, the scientific justification for each step and continuity of care — not the number of cells or the price.

The difference is not simply receiving stem cells. It is understanding why a treatment is recommended, what evidence supports it, and whether its potential benefits justify its risks and cost.

Green Healthcare International — Patient Advocacy & Regenerative Medicine Education
Ask about an advanced protocolRegenerative medicine education →
Free evidence check

What would you like to be treated?

Choose one or more conditions. You’ll see right away how strong the human evidence is — then send the form and a Green Healthcare patient advocate will reply with an independent summary for your case.

  • Real published data, not testimonials
  • Approved, investigational or unproven — clearly labeled
  • Physician, laboratory and price questions answered
1Conditions
2About you

A real patient advocate replies, usually within one business day. We never sell your information.

Evidence guide

Is there a real solution — and what data support it?

Our plain-language reading of published human research as of October 2026. Evidence differs by cell type, dose, delivery method and condition, so a clinic’s specific protocol must be judged on its own data.

Autoimmune & inflammatory

Mixed evidence

Crohn’s disease

The strongest data are for injecting donor fat-derived cells directly into complex perianal fistulas — and even that result did not hold up.

  • Europe approved one such product (darvadstrocel, Alofisel) in 2018, then it was withdrawn in December 2024 after a larger phase 3 trial (ADMIRE-CD II) missed its main goal.
  • Intravenous stem cell infusions for intestinal Crohn’s disease remain experimental.
  • Blood-stem-cell transplant has been studied for severe, treatment-resistant Crohn’s, with serious side effects.

Proven options to discuss firstMany approved biologic and small-molecule medicines; surgery for some fistulas.

Limited evidence

Psoriasis

Only small, early studies of umbilical-cord stem cells exist, mostly measuring safety.

  • No controlled trial has shown stem cells work as well as standard treatment.
  • No regulator has approved a stem cell therapy for psoriasis.

Proven options to discuss firstApproved biologic medicines clear or nearly clear the skin in many patients.

Mixed evidence

Lupus (SLE)

Early open-label studies from China reported improvement in some patients with severe lupus nephritis, but the only placebo-controlled trial found no added benefit.

  • The randomized trial (Deng et al., 2017) saw similar results with and without stem cells.
  • A different, hospital-based treatment — CAR-T cell therapy, which is not stem cell therapy — has produced drug-free remissions in small European studies and is in trials.

Proven options to discuss firstRheumatology care with approved medicines; ask about CAR-T clinical trials if your lupus is severe.

Limited evidence

Rheumatoid arthritis

Phase 1/2 trials of umbilical-cord and fat-derived cells show acceptable short-term safety and some symptom improvement.

  • No large, controlled trial has confirmed lasting benefit.
  • No stem cell therapy is approved for rheumatoid arthritis.

Proven options to discuss firstDisease-modifying and biologic medicines, which prevent joint damage when started early.

Metabolic & liver

Promising · in clinical trials

Type 1 diabetes

This is one of the most exciting areas of research — but the treatments that work best in trials are not what most clinics offer.

  • Lab-grown insulin-producing islet cells made from stem cells (Vertex’s zimislecel): in a 2025 New England Journal of Medicine report, 10 of 12 fully dosed patients no longer needed insulin injections at one year. It requires lifelong immune-suppressing drugs, is in a pivotal trial and is not available outside it.
  • Blood-stem-cell transplant in newly diagnosed patients gave temporary insulin freedom, with significant risks.
  • Mesenchymal stem cell (MSC) infusions offered by clinics have shown only modest effects on the body’s own insulin production in small trials.

Proven options to discuss firstModern insulin pumps and sensors; ask your endocrinologist about islet-cell clinical trials.

Advanced protocol performed — ask for more details. A participating provider performs an advanced type 1 diabetes protocol. Select it in the form to receive the protocol, physician, laboratory, published data and regulatory status.

Limited evidence

Type 2 diabetes

Small trials, mostly from China, report lower insulin needs or HbA1c in some patients for several months.

  • Results are inconsistent and long-term data are lacking.
  • No stem cell therapy is approved for type 2 diabetes.

Proven options to discuss firstLifestyle change, GLP-1 and other proven medicines, and metabolic surgery for some patients.

Advanced protocol performed — ask for more details. A participating provider performs an advanced type 2 diabetes protocol. Select it in the form to receive the protocol, physician, laboratory, published data and regulatory status.

Promising · in clinical trials

Liver cirrhosis & liver disease

Dozens of small randomized trials, mainly in China, Iran and India, report short-term improvement in liver scores (such as MELD and albumin) after stem cell infusions.

  • Study quality varies and the effect on long-term survival is still uncertain.
  • No stem cell therapy for cirrhosis is approved by the US FDA or the European Medicines Agency.
  • Liver transplant remains the only curative option for end-stage disease.

Proven options to discuss firstTreating the cause (alcohol, hepatitis, fatty liver), hepatology follow-up and transplant evaluation.

Advanced protocol performed — ask for more details. A participating provider performs an advanced liver cirrhosis & liver disease protocol. Select it in the form to receive the protocol, physician, laboratory, published data and regulatory status.

Neurological & spine

Strongest evidence

Multiple sclerosis

Of everything on this list, MS has the strongest evidence — for one specific procedure: autologous hematopoietic stem cell transplant (aHSCT).

  • aHSCT uses chemotherapy to reset the immune system, then returns your own blood stem cells. In the MIST randomized trial (JAMA, 2019), far fewer patients with relapsing MS got worse than on standard medicines.
  • It is best suited to highly active relapsing MS. It carries real risks — serious infection, infertility and a small risk of death (well under 1% in experienced centers) — and is done in hospital transplant units, not outpatient clinics.
  • Mesenchymal stem cell infusions for MS remain experimental; the MESEMS trial found no significant effect.

Proven options to discuss firstHighly effective MS medicines; ask a neurologist whether you meet aHSCT criteria.

Advanced protocol performed — ask for more details. A participating provider performs an advanced MS protocol. Select it in the form to receive the protocol, physician, laboratory, published data and regulatory status.

Limited evidence

Spinal cord injury

Japan granted conditional, time-limited approval to a patient’s-own-cell product (Stemirac) in 2018 for recent injuries, based on a small study without a control group.

  • Trials elsewhere show the cells are generally safe, but no proven recovery of movement or sensation.
  • Results from chronic (older) injuries are weaker still.

Proven options to discuss firstSpecialized spinal-cord rehabilitation; ask about registered clinical trials.

Joints & pain

Mixed evidence

Osteoarthritis

Knee osteoarthritis is the most-studied stem cell use in orthopedics — and the largest trial was disappointing.

  • The randomized MILES trial (2023) found bone-marrow, fat-derived and umbilical-cord cell injections no better than a single steroid injection at one year.
  • Some smaller trials report pain relief; cartilage regrowth has not been convincingly shown.
  • South Korea approved a cord-blood cell product (Cartistem) for cartilage defects in 2012.

Proven options to discuss firstExercise therapy, weight management, injections and joint replacement when needed.

Limited evidence

Chronic pain

Evidence depends entirely on what is causing the pain.

  • Trials for disc-related back pain have had mixed results.
  • For most other pain conditions, studies are small and short.
  • An accurate diagnosis of the pain source should come first.

Proven options to discuss firstA pain-medicine or physiatry evaluation to identify the cause.

Heart & lungs

Mixed evidence

Myocardial regeneration (heart)

Two decades of trials after heart attack and in heart failure show small or no improvement in heart function.

  • The large DREAM-HF trial (2023) missed its main goal, though it reported fewer heart attacks and strokes.
  • Some influential early research in this field was later retracted.
  • No stem cell therapy for the heart is approved in the US or Europe.

Proven options to discuss firstGuideline heart-failure medicines, cardiac rehabilitation and devices.

Advanced protocol performed — ask for more details. A participating provider performs an advanced heart protocol. Select it in the form to receive the protocol, physician, laboratory, published data and regulatory status.

Mixed evidence

Severe COVID-19 / lung damage

Many small trials during the pandemic tested stem cells for severe COVID-19 lung injury; some suggested lower mortality, but larger trials were inconclusive.

  • No stem cell therapy is approved for COVID-19 or long COVID.
  • This is not a reason to travel for treatment.

Proven options to discuss firstPulmonary follow-up and rehabilitation.

Limited evidence

COPD

A US placebo-controlled trial (Weiss et al., 2013) found stem cells safe but saw no improvement in lung function.

  • Later studies are small and uncontrolled.
  • The American Lung Association cautions patients about unproven stem cell clinics.

Proven options to discuss firstInhaled medicines, pulmonary rehabilitation, oxygen and stopping smoking.

Aesthetic & longevity

Limited evidence

Alopecia (hair loss)

Small studies of fat-derived cells, stem-cell “conditioned media” and exosomes report gains in hair density.

  • Most are small, short and not blinded.
  • Exosome products are not FDA-approved, and the FDA has warned consumers about them.

Proven options to discuss firstMinoxidil, finasteride and PRP; JAK-inhibitor medicines are approved for alopecia areata.

Not established

Anti-aging therapy

No stem cell therapy is approved — or proven — to slow or reverse aging.

  • Small trials in age-related frailty have shown mixed signals.
  • Biological-age tests can track change but do not prove a treatment works.

Proven options to discuss firstExercise, sleep, blood pressure and metabolic control — the best-proven healthy-aging measures.

Not established

Rejuvenation therapy

“Rejuvenation” is a marketing term, not a medical diagnosis, and there is no reliable evidence that stem cell infusions rejuvenate the body.

  • Ask exactly what is being injected, what it is expected to change and how that will be measured.

Proven options to discuss firstA preventive-health check-up with measurable goals.

Not established

Health & beauty (skin)

Stem-cell “extracts” and exosome facials are cosmetic products with little clinical data.

  • They are not approved as medical treatments, and product quality varies widely.

Proven options to discuss firstDermatologist-guided skincare, sun protection and proven aesthetic procedures.

Before choosing a clinic

Ask these five questions

The answers tell you more than any price or testimonial.

See all 20 questions →
01Who is the treating physician?

Research the physician’s medical credentials, specialty, years of experience and experience treating your specific condition. Ask who will administer the treatment and who will manage complications.

02Who oversees the laboratory?

Ask whether the laboratory has qualified professionals, including microbiologists experienced in cell processing and contamination control. A microbiologist’s involvement is valuable, but it does not replace physician oversight, validated manufacturing procedures or independent quality testing.

03How are the stem cells processed and tested?

Request information about cell origin, donor screening, sterility testing, cell identity, viability, traceability and laboratory quality standards.

04Is the treatment scientifically supported?

Ask for published human clinical evidence for your specific condition, an explanation of potential risks, and the treatment’s regulatory status. Many stem cell treatments remain experimental and are not proven to be safe or effective for the conditions for which they are marketed.

05What does the quoted price actually include?

Compare medical evaluations, laboratory testing, cell processing, administration, follow-up care, accommodation, transportation and potential additional charges.

Our recommendation

Choose the science, the physician and the laboratory before choosing the price.

At Green Healthcare International, we believe patients deserve transparent information, independent guidance and a clear understanding of their options before making healthcare decisions abroad. We are advocates and coordinators: we do not provide treatment ourselves, conduct research or claim cures.

Start my evidence checkVisit the education center →

Sources and further reading

Source links checked October 9, 2026. Research and regulatory status change; confirm the latest with the responsible authority and your physician.

VIP Healthcare · By application

When you want more than most.

A private, by-application program with a dedicated expert patient advocate, hand-selected physicians and discreet coordination from the first conversation to long-term follow-up.

Click here to explore VIP Healthcare